TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent stateSatoru Matsuda, Shyamala Maheswaran, David T. Ting et al.|Cell Reports|2023Cited by 58
Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibodyDouglas S. Micalizzi, Daniel A. Haber, Dante Che et al.|Proceedings of the National Academy of Sciences|2022Cited by 21
A Gene Panel Associated With Abemaciclib Utility in <i>ESR1</i>-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor ProgressionJamie O. Brett, Seth A. Wander, Taronish D. Dubash et al.|JCO Precision Oncology|2023Cited by 16
Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target InhibitionNezihi Murat Karabacak, Shyamala Maheswaran, Yu Zheng et al.|Cancer Research|2022Cited by 4
Abstract PD2-03: Association between co-existing genomic alterations and abemaciclib benefit in patients with metastatic hormone receptor-positive breast cancer with ESR1 mutations following disease progression on prior endocrine therapy plus palbociclib or ribociclibJamie O. Brett, Seth A. Wander, Taronish D. Dubash et al.|Cancer Research|2022Cited by 1